Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000425777 | SCV000511480 | likely pathogenic | not provided | 2016-09-13 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001835792 | SCV002087511 | likely pathogenic | Familial aplasia of the vermis | 2021-01-23 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004725212 | SCV005337183 | likely pathogenic | RPGRIP1L-related disorder | 2024-05-10 | no assertion criteria provided | clinical testing | The RPGRIP1L c.3187G>T variant is predicted to result in premature protein termination (p.Glu1063*). To our knowledge, this variant has not been reported in individuals with RPGRIP1L-related disorders in the literature. This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Nonsense variants in RPGRIP1L are expected to be pathogenic. This variant is interpreted as likely pathogenic. |